Ho Min Jeon

Title: Innovations by Ho Min Jeon in Diabetes Management

Introduction

Ho Min Jeon is an accomplished inventor based in Yongin-si, South Korea. He has made significant contributions to the field of diabetes management through his innovative work on artificial pancreas technology. His dedication to improving the lives of individuals with diabetes is evident in his patented inventions.

Latest Patents

Ho Min Jeon holds a patent for a "Method for controlling artificial pancreas including insulin patch and device therefor." This invention provides a novel approach to managing insulin delivery through an insulin patch. The method involves obtaining blood glucose information from a sensor within the patch, inputting this data into a neural network, estimating pump parameters, and simulating the insulin patch's performance. This innovative approach aims to enhance the effectiveness of insulin delivery systems.

Career Highlights

Ho Min Jeon is currently associated with Eoflow Co., Ltd., a company focused on developing advanced diabetes management solutions. His work at Eoflow has positioned him as a key player in the field of medical technology, particularly in the area of insulin delivery systems. His contributions have the potential to transform how diabetes is managed globally.

Collaborations

Ho Min Jeon has collaborated with notable colleagues, including Ian G Welsford and Inwook Bin. These partnerships have fostered a collaborative environment that encourages innovation and the development of cutting-edge solutions in diabetes care.

Conclusion

Ho Min Jeon's work exemplifies the spirit of innovation in the medical technology sector. His patented methods for controlling artificial pancreas systems represent a significant advancement in diabetes management. Through his contributions, he continues to make a positive impact on the lives of those living with diabetes.